Exhibit 99.1
![]() |
Q3 2003 RESULTS PRESENTATION – 5 November 2003
Basingstoke, UK - 16 October 2003 - Shire Pharmaceuticals Group plc (LSE: SHP, NASDAQ: SHPGY; TSX: SHQ) will announce third quarter 2003 earnings on Wednesday, 5 November 2003.
Results announcement time: | 12:00 GMT / 07:00 ET | |
Conference call time: | 14:00 GMT / 09:00 ET |
Live conference call:
The details of the live conference call are as follows:
UK dial in | + 44 1452 569 393 | |
US / Canada dial in | 1866 434 1089 | |
Password | Shire Pharmaceuticals |
Live audio webcast:
There will also be a live audio webcast available, accessible throughwww.shire.com in the investor relations section. A slide presentation to accompany the call will also be available on the Shire website.
Replay:
A replay of the presentation will be available for 2 weeks. Details are as follows:
UK International no: | + 44 1452 55 00 00 | |
UK PIN (access) no: | 608360# | |
US no: | 1866 276 1167 | |
US PIN (access) no: | 608360# | |
Webcast Replay | www.shire.com, in the investor relations section |
If you have any problems accessing this, please contact: Souheil Salah on: +44 (0) 1256 894160
End
For further information please contact:
Global Investor Relations | |
Cléa Rosenfeld | +44 (0)1256 894 160 |
Notes to editors
Shire Pharmaceuticals Group plc
Shire Pharmaceuticals Group plc (Shire) is a global specialty pharmaceutical company with a strategic focus on meeting the needs of the specialist physician and currently has a range of projects and products in the areas of central nervous system (CNS), gastrointestinal (GI), and renal diseases. Shire has operations in the world’s key pharmaceutical markets (US, Canada, UK, France, Italy, Spain and Germany) as well as a specialist drug delivery unit in the US.
For further information on Shire, please visit the Company’s website:www.shire.com